Vorsetuzumab mafodotin Uses, Dosage, Side Effects and more
Vorsetuzumab mafodotin is under investigation in clinical trial NCT01677390 (A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma).
| Trade Name | Vorsetuzumab mafodotin |
| Generic | Vorsetuzumab mafodotin |
| Vorsetuzumab mafodotin Other Names | Vorsetuzumab mafodotin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
